126 related articles for article (PubMed ID: 15148458)
21. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronan and peritoneal ultrafiltration: a test of the "filter-cake" hypothesis.
Rosengren BI; Carlsson O; Rippe B
Am J Kidney Dis; 2001 Jun; 37(6):1277-85. PubMed ID: 11382699
[TBL] [Abstract][Full Text] [Related]
23. N-acetylcysteine modulates effect of the iron isomaltoside on peritoneal mesothelial cells.
Misian M; Baum E; Breborowicz A
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991316
[TBL] [Abstract][Full Text] [Related]
24. Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid.
Ogata S; Yorioka N; Kiribayashi K; Naito T; Kuratsune M; Nishida Y
Adv Perit Dial; 2003; 19():2-5. PubMed ID: 14763024
[TBL] [Abstract][Full Text] [Related]
25. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
26. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
27. Sulodexide modulates the dialysate effect on the peritoneal mesothelium.
Misian M; Baum E; Breborowicz A
J Physiol Pharmacol; 2019 Dec; 70(6):. PubMed ID: 32203941
[TBL] [Abstract][Full Text] [Related]
28. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid.
Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK
Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332
[TBL] [Abstract][Full Text] [Related]
29. Effect of dialysate composition on the apoptosis and proliferation of human peritoneal mesothelial cells and protein expression of Fas and c-Myc.
Zheng ZH; Ye RG; Bergström J; Lindholm B
Adv Perit Dial; 2000; 16():31-5. PubMed ID: 11045257
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
Davenport A; Fernando RL; Varghese Z
Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
[TBL] [Abstract][Full Text] [Related]
31. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
[TBL] [Abstract][Full Text] [Related]
32. Pyruvate anions neutralize peritoneal dialysate cytotoxicity.
Mahiout A; Brunkhorst R
Nephrol Dial Transplant; 1995; 10(3):391-4. PubMed ID: 7792037
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
[TBL] [Abstract][Full Text] [Related]
34. [Influence of different pharmacological agents in the ex vivo proliferation of mesothelial cells obtained from the peritoneal effluent of patients treated with peritoneal dialysis].
Castro MA; Bajo MA; del Peso G; Larrocha C; Castro MJ; Sánchez-Tomero JA; Cirugeda A; Aguilera A; Alvarez V; Costero O; Vara F; Fernández-Chacón JL; Selgas R
Nefrologia; 2003; 23(3):243-51. PubMed ID: 12891939
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan decreases peritoneal fluid absorption: effect of molecular weight and concentration of hyaluronan.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1999 Feb; 55(2):667-73. PubMed ID: 9987091
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of hyaluronic acid by human peritoneal mesothelial cells: effect of cytokines and dialysate.
Breborowicz A; Korybalska K; Grzybowski A; Wieczorowska-Tobis K; Martis L; Oreopoulos DG
Perit Dial Int; 1996; 16(4):374-8. PubMed ID: 8863330
[TBL] [Abstract][Full Text] [Related]
37. L-2-oxothiazolidine-4-carboxylic acids slow down dialysate-induced senescence in human peritoneal mesothelial cells.
Sosinska-Zawierucha P; Mackowiak B; Begier-Krasinska B; Hoppe K; Breborowicz A
J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802216
[TBL] [Abstract][Full Text] [Related]
38. l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitro.
Breborowicz A; Wisniewska J; Moberly JB; Oreopoulos DG
Am J Kidney Dis; 1999 Oct; 34(4):663-8. PubMed ID: 10516347
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan preserves peritoneal membrane transport properties.
Guo QY; Peng WX; Cheng HH; Ye RG; Lindholm B; Wang T
Perit Dial Int; 2001; 21(2):136-42. PubMed ID: 11330556
[TBL] [Abstract][Full Text] [Related]
40. Intraperitoneal addition of hyaluronan improves peritoneal dialysis efficiency.
Wang T; Cheng HH; Heimbürger O; Chen C; Waniewski J; Bergström J; Lindholm B
Perit Dial Int; 1999; 19 Suppl 2():S106-11. PubMed ID: 10406503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
